医学
克林霉素
菌血症
感染性休克
庆大霉素
金黄色葡萄球菌
内科学
抗生素
死亡率
流行病学
回顾性队列研究
外科
儿科
胃肠病学
败血症
微生物学
生物
遗传学
细菌
作者
Hugo Paganini,Paula Della Latta,Adriana Soto,Lidia Casimir,Andrea Lo Monaco,Virginia Verdaguer,Griselda Berberián,María Teresa Rosanova,Fernando Álvez González,Claudia Sarkis
出处
期刊:PubMed
日期:2010-08-01
卷期号:108 (4): 311-7
被引量:12
标识
DOI:10.1590/s0325-00752010000400004
摘要
Community-acquired methicillin-resistant Staphylococcus aureus (CAMRSa) emerged in recent years. Few studies analyzed the impact of these infections in bacteremias (B).To analyze clinical, epidemiological, microbiological and outcome of CASa B between two periods (Period I: 1993-2004, and Period II: 2004-2007).Retrospective, observational and comparative study. All children older than 1 month of age and CASaB were included.During the study period 647 SaB were diagnosed (Period I: 499 and Period II: 148). Of them, 140 (28%) and 49 (33%) were CSaB, respectively. The median age of patients was 5.9 and 4.8 years, respectively (p= NS). Clinical foci of infection and septic shock were more frequent in the period I (78% vs. 47%) and (5% vs. 16%) (p <0.05), respectively. Skin infection and septic shock were similar in both periods (78% vs. 67% and 5% vs. 8%; p= NS). Four CAMRSa B (3%) were diagnosed during the first period. One predisposing factor was identified in all cases. Inversely, 23 cases (47%) were diagnosed during the Period II (p <0.05). Resistance rates to clindamycin and gentamicin were more high during the second period (10% vs. 2% and 20% vs. 3%, respectively) (p <0.05). Patients in the second period had longer antibiotic treatment (X 16.6 vs. 10.1 days) and more frequent inappropriate treatment at admission (53% vs. 5%) (p <0.05). Hospital stay time was longer during de first period (19.2 vs. 12.2 days) (p <0.05). The mortality rate was higher in the first period (13% vs. 4%) (p= NS).A significant increase of CAMRSa B were detected in recent years. It is necessary to evaluate the empirical treatment of severe community infections in children in our country.
科研通智能强力驱动
Strongly Powered by AbleSci AI